Neurocrine Biosciences Stock Market Value
| NBIX Stock | USD 125.65 0.65 0.52% |
| Symbol | Neurocrine |
Neurocrine Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurocrine Biosciences. If investors know Neurocrine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurocrine Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.512 | Earnings Share 3.74 | Revenue Per Share 22.422 | Quarterly Revenue Growth 0.247 | Return On Assets 0.118 |
The market value of Neurocrine Biosciences is measured differently than its book value, which is the value of Neurocrine that is recorded on the company's balance sheet. Investors also form their own opinion of Neurocrine Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Neurocrine Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurocrine Biosciences' market value can be influenced by many factors that don't directly affect Neurocrine Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurocrine Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurocrine Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurocrine Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neurocrine Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neurocrine Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neurocrine Biosciences.
| 02/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in Neurocrine Biosciences on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding Neurocrine Biosciences or generate 0.0% return on investment in Neurocrine Biosciences over 270 days. Neurocrine Biosciences is related to or competes with Amphastar, Collegium Pharmaceutical, Ironwood Pharmaceuticals, ANI Pharmaceuticals, Alkermes Plc, Avadel Pharmaceuticals, and Intracellular. Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatr... More
Neurocrine Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neurocrine Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neurocrine Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 19.06 | |||
| Value At Risk | (2.10) | |||
| Potential Upside | 3.1 |
Neurocrine Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neurocrine Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neurocrine Biosciences' standard deviation. In reality, there are many statistical measures that can use Neurocrine Biosciences historical prices to predict the future Neurocrine Biosciences' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.71) | |||
| Treynor Ratio | (0.19) |
Neurocrine Biosciences Backtested Returns
Neurocrine Biosciences has Sharpe Ratio of -0.0876, which conveys that the firm had a -0.0876% return per unit of risk over the last 3 months. Neurocrine Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neurocrine Biosciences' Risk Adjusted Performance of (0.06), standard deviation of 2.89, and Mean Deviation of 1.5 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.35, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neurocrine Biosciences will likely underperform. At this point, Neurocrine Biosciences has a negative expected return of -0.26%. Please make sure to verify Neurocrine Biosciences' value at risk, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if Neurocrine Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.05 |
Very weak reverse predictability
Neurocrine Biosciences has very weak reverse predictability. Overlapping area represents the amount of predictability between Neurocrine Biosciences time series from 29th of February 2024 to 13th of July 2024 and 13th of July 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neurocrine Biosciences price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Neurocrine Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 193.71 |
Neurocrine Biosciences lagged returns against current returns
Autocorrelation, which is Neurocrine Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neurocrine Biosciences' stock expected returns. We can calculate the autocorrelation of Neurocrine Biosciences returns to help us make a trade decision. For example, suppose you find that Neurocrine Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neurocrine Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neurocrine Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neurocrine Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neurocrine Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Neurocrine Biosciences Lagged Returns
When evaluating Neurocrine Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neurocrine Biosciences stock have on its future price. Neurocrine Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neurocrine Biosciences autocorrelation shows the relationship between Neurocrine Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Neurocrine Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Neurocrine Stock Analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.